白藜芦醇对过敏性气道疾病小鼠模型的气道重塑和气道高反应性具有保护作用。

Pathobiology of aging & age related diseases Pub Date : 2011-01-01 Epub Date: 2011-06-01 DOI:10.3402/pba.v1i0.7134
Simon G Royce, William Dang, Gao Yuan, Jenny Tran, Assam El Osta, Tom C Karagiannis, Mimi L K Tang
{"title":"白藜芦醇对过敏性气道疾病小鼠模型的气道重塑和气道高反应性具有保护作用。","authors":"Simon G Royce,&nbsp;William Dang,&nbsp;Gao Yuan,&nbsp;Jenny Tran,&nbsp;Assam El Osta,&nbsp;Tom C Karagiannis,&nbsp;Mimi L K Tang","doi":"10.3402/pba.v1i0.7134","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>New therapies for asthma which can address three main interrelated features of the disease, airway inflammation, airway remodeling and airway hyperreactivity, are urgently required. Resveratrol, a well known red wine polyphenol has received much attention due to its potential anti-aging properties. This compound is an agonist of silent information regulator two histone deacetylases and has many effects that are relevant to key aspects of the pathophysiology of asthma including inflammation, cell proliferation and fibrosis. Therefore, resveratrol may offer a novel asthma therapy that simultaneously inhibits airway inflammation, and airway remodeling which are the main contributors to airway hyperreactivity and irreversible lung function loss.</p><p><strong>Methods: </strong>We evaluated the effects of systemic resveratrol treatment in a murine model of chronic allergic airways disease which displays most of the clinicopathological features of severe human asthma. Wild-type Balb/c mice with allergic airways disease were treated with 12.5 mg/kg resveratrol or vehicle control. Airway inflammation was assessed by bronchoalveolar lavage fluid cell counts and histological examination of lung tissue sections. Further, remodeling was assessed by morphometric analysis and lung function was assessed by invasive plethysmography measurement of airway resistance and dynamic compliance.</p><p><strong>Results: </strong>Mice treated with resveratrol exhibited reduced tissue inflammation as compared to vehicle treated mice (p<0.05). Additionally, resveratrol treatment resulted in reduced subepithelial collagen deposition as compared to vehicle treated mice (p<0.05) and attenuated airway hyperreactivity (p<0.05).</p><p><strong>Conclusions: </strong>These novel findings demonstrate that treatment with resveratrol can reduce structural airway remodeling changes and hyperreactivity. This has important implications for the development of new therapeutic approaches to asthma.</p>","PeriodicalId":89611,"journal":{"name":"Pathobiology of aging & age related diseases","volume":"1 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3402/pba.v1i0.7134","citationCount":"48","resultStr":"{\"title\":\"Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways disease.\",\"authors\":\"Simon G Royce,&nbsp;William Dang,&nbsp;Gao Yuan,&nbsp;Jenny Tran,&nbsp;Assam El Osta,&nbsp;Tom C Karagiannis,&nbsp;Mimi L K Tang\",\"doi\":\"10.3402/pba.v1i0.7134\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>New therapies for asthma which can address three main interrelated features of the disease, airway inflammation, airway remodeling and airway hyperreactivity, are urgently required. Resveratrol, a well known red wine polyphenol has received much attention due to its potential anti-aging properties. This compound is an agonist of silent information regulator two histone deacetylases and has many effects that are relevant to key aspects of the pathophysiology of asthma including inflammation, cell proliferation and fibrosis. Therefore, resveratrol may offer a novel asthma therapy that simultaneously inhibits airway inflammation, and airway remodeling which are the main contributors to airway hyperreactivity and irreversible lung function loss.</p><p><strong>Methods: </strong>We evaluated the effects of systemic resveratrol treatment in a murine model of chronic allergic airways disease which displays most of the clinicopathological features of severe human asthma. Wild-type Balb/c mice with allergic airways disease were treated with 12.5 mg/kg resveratrol or vehicle control. Airway inflammation was assessed by bronchoalveolar lavage fluid cell counts and histological examination of lung tissue sections. Further, remodeling was assessed by morphometric analysis and lung function was assessed by invasive plethysmography measurement of airway resistance and dynamic compliance.</p><p><strong>Results: </strong>Mice treated with resveratrol exhibited reduced tissue inflammation as compared to vehicle treated mice (p<0.05). Additionally, resveratrol treatment resulted in reduced subepithelial collagen deposition as compared to vehicle treated mice (p<0.05) and attenuated airway hyperreactivity (p<0.05).</p><p><strong>Conclusions: </strong>These novel findings demonstrate that treatment with resveratrol can reduce structural airway remodeling changes and hyperreactivity. This has important implications for the development of new therapeutic approaches to asthma.</p>\",\"PeriodicalId\":89611,\"journal\":{\"name\":\"Pathobiology of aging & age related diseases\",\"volume\":\"1 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3402/pba.v1i0.7134\",\"citationCount\":\"48\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pathobiology of aging & age related diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3402/pba.v1i0.7134\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2011/6/1 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathobiology of aging & age related diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3402/pba.v1i0.7134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2011/6/1 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 48

摘要

背景:迫切需要新的哮喘治疗方法,以解决疾病的三个主要相互关联的特征:气道炎症、气道重塑和气道高反应性。白藜芦醇是一种众所周知的红葡萄酒多酚,因其潜在的抗衰老特性而受到广泛关注。该化合物是沉默信息调节剂两种组蛋白去乙酰化酶的激动剂,具有许多与哮喘病理生理学关键方面相关的作用,包括炎症、细胞增殖和纤维化。因此,白藜芦醇可能提供一种同时抑制气道炎症和气道重塑的新型哮喘治疗方法,气道炎症和气道重塑是气道高反应性和不可逆肺功能丧失的主要原因。方法:我们评估了全身白藜芦醇治疗慢性变应性气道疾病小鼠模型的效果,该模型显示了人类严重哮喘的大部分临床病理特征。用12.5 mg/kg白藜芦醇或对照治疗变应性气道疾病野生型Balb/c小鼠。通过支气管肺泡灌洗液细胞计数和肺组织切片组织学检查评估气道炎症。此外,通过形态计量学分析评估重塑,通过有创容积脉搏波测量气道阻力和动态顺应性评估肺功能。结果:与对照组小鼠相比,白藜芦醇治疗小鼠的组织炎症减轻(结论:这些新发现表明白藜芦醇治疗可以减少气道结构重塑改变和高反应性。这对哮喘新治疗方法的发展具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways disease.

Background: New therapies for asthma which can address three main interrelated features of the disease, airway inflammation, airway remodeling and airway hyperreactivity, are urgently required. Resveratrol, a well known red wine polyphenol has received much attention due to its potential anti-aging properties. This compound is an agonist of silent information regulator two histone deacetylases and has many effects that are relevant to key aspects of the pathophysiology of asthma including inflammation, cell proliferation and fibrosis. Therefore, resveratrol may offer a novel asthma therapy that simultaneously inhibits airway inflammation, and airway remodeling which are the main contributors to airway hyperreactivity and irreversible lung function loss.

Methods: We evaluated the effects of systemic resveratrol treatment in a murine model of chronic allergic airways disease which displays most of the clinicopathological features of severe human asthma. Wild-type Balb/c mice with allergic airways disease were treated with 12.5 mg/kg resveratrol or vehicle control. Airway inflammation was assessed by bronchoalveolar lavage fluid cell counts and histological examination of lung tissue sections. Further, remodeling was assessed by morphometric analysis and lung function was assessed by invasive plethysmography measurement of airway resistance and dynamic compliance.

Results: Mice treated with resveratrol exhibited reduced tissue inflammation as compared to vehicle treated mice (p<0.05). Additionally, resveratrol treatment resulted in reduced subepithelial collagen deposition as compared to vehicle treated mice (p<0.05) and attenuated airway hyperreactivity (p<0.05).

Conclusions: These novel findings demonstrate that treatment with resveratrol can reduce structural airway remodeling changes and hyperreactivity. This has important implications for the development of new therapeutic approaches to asthma.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信